학술논문
455P Post progression treatments after endocrine therapy (ET) plus palbociclib in patients with HR+/HER2- metastatic breast cancer (MBC): A prospective, real-world study
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S372-S372
Subject
Language
ISSN
0923-7534